Cancer Treatment Reviews
Volume 30, Issue 5 , Pages 461-472, August 2004

Histone deacetylase inhibitors – a new tool to treat cancer

  • Raz Somech

      Affiliations

    • Laboratory of Molecular Hemato-Oncology, Sheba Cancer Research Center, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel-Aviv University, Israel
    • Dana Children's Hospital, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel-Aviv University, Israel
    • Corresponding Author InformationCorresponding author. Tel.: +972-3-5302397; fax: +972-3-5302377
    • ,
  • Shai Izraeli

      Affiliations

    • Laboratory of Molecular Hemato-Oncology, Sheba Cancer Research Center, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel-Aviv University, Israel
    • ,
  • Amos J Simon

      Affiliations

    • Laboratory of Molecular Hemato-Oncology, Sheba Cancer Research Center, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel-Aviv University, Israel

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(04)00078-7

doi:10.1016/j.ctrv.2004.04.006

Cancer Treatment Reviews
Volume 30, Issue 5 , Pages 461-472, August 2004

Article Tools

* Image Usage & Resolution